Literature DB >> 36112199

Neuropsychological functioning in children and adolescents with anti-NMDA receptor encephalitis (anti-NMDARE).

Karine Hageboutros1,2, Nina Hattiangadi Thomas3,4, Melissa Hutchinson3,5, Brenda Banwell6,7, Katherine T Baum3,4.   

Abstract

The objective of this study was to describe neuropsychological functioning and associated medical features in pediatric patients with anti-NMDA receptor encephalitis (anti-NMDARE). Retrospective data were collected from electronic medical records and neuropsychological reports of 15 children and adolescents with cerebral spinal fluid antibody-confirmed anti-NMDARE who were 7-21 years old at the time of the neuropsychological evaluation. The median time between treatment initiation for anti-NMDARE and neuropsychological testing was 228 days (IQR 431, range 41-927). Consistent with the limited literature, this pediatric sample with anti-NMDARE generally had average IQs, but had scores falling in the low average range on tests of verbal and visual memory as well as aspects of executive functioning (set shifting and phonemic verbal fluency). Other relative weaknesses were observed in visuo-constructional ability and reading comprehension. Future prospective studies are needed to replicate these data and explore disease and treatment variables that reduce or exacerbate the risk for neuropsychological sequelae, while longitudinal analyses are required to better characterize academic, vocational, and social outcomes.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Autoimmune; Cognitive; Neuropsychology; Outcomes; Pediatric

Year:  2022        PMID: 36112199     DOI: 10.1007/s00415-022-11372-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   6.682


  26 in total

1.  Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma.

Authors:  M S Zandi; S R Irani; G Follows; A M Moody; P Molyneux; A Vincent
Journal:  Neurology       Date:  2009-12-08       Impact factor: 9.910

2.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

3.  Pediatric autoimmune encephalitis in Denmark during 2011-17: A nationwide multicenter population-based cohort study.

Authors:  Magnus Spangsberg Boesen; Alfred Peter Born; Magnus Christian Lydolph; Morten Blaabjerg; Malene Landbo Børresen
Journal:  Eur J Paediatr Neurol       Date:  2019-03-30       Impact factor: 3.140

4.  Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong.

Authors:  Alvin Chi-Chung Ho; Sophelia Hoi-Shan Chan; Eric Chan; Sheila Suet-Na Wong; Sharon Tsui-Hang Fung; Sharon Wan-Wah Cherk; Eva Lai-Wah Fung; Kam-Hung Ma; Kwing-Wan Tsui; Eric Kin-Cheong Yau; Virginia Chun-Nei Wong
Journal:  Brain Dev       Date:  2018-03-26       Impact factor: 1.961

Review 5.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

Authors:  Josep Dalmau; Eric Lancaster; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

6.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

7.  Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.

Authors:  T Iizuka; F Sakai; T Ide; T Monzen; S Yoshii; M Iigaya; K Suzuki; D R Lynch; N Suzuki; T Hata; J Dalmau
Journal:  Neurology       Date:  2007-09-26       Impact factor: 9.910

8.  Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents.

Authors:  Nicole R Florance; Rebecca L Davis; Christopher Lam; Christina Szperka; Lei Zhou; Saba Ahmad; Cynthia J Campen; Heather Moss; Nadja Peter; Amy J Gleichman; Carol A Glaser; David R Lynch; Myrna R Rosenfeld; Josep Dalmau
Journal:  Ann Neurol       Date:  2009-07       Impact factor: 10.422

9.  N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children.

Authors:  Sukhvir Wright; Yael Hacohen; Leslie Jacobson; Shakti Agrawal; Rajat Gupta; Sunny Philip; Martin Smith; Ming Lim; Evangeline Wassmer; Angela Vincent
Journal:  Arch Dis Child       Date:  2015-01-30       Impact factor: 3.791

Review 10.  Pediatric Anti-N-Methyl-d-Aspartate Receptor Encephalitis: A Review with Pooled Analysis and Critical Care Emphasis.

Authors:  Kenneth E Remy; Jason W Custer; Joshua Cappell; Cortney B Foster; Nan A Garber; L Kyle Walker; Liliana Simon; Dayanand Bagdure
Journal:  Front Pediatr       Date:  2017-11-24       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.